Maca Menopause Randomized Trial: What the Evidence Says

Quick Answer

Maca Menopause Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Common physical symptoms include decreased skin elasticity, reduced libido, headaches, cardiovascular issues, hot flashes, sleep disturbances, and facial flushing. [Kim Ji-Hyun (2025); evidence level 1]
• Psychological symptoms frequently include increased irritability and depressive symptomatology, such as feelings of worthlessness, fatigue, lack of motivation, and diminished concentration. [Kim Ji-Hyun (2025); evidence level 1]
• However, their side effects can negatively impact treatment adherence.One of the most frequently reported and disruptive side effects is sexual dysfunction, which can profoundly affect an individual's daily life.,,When such side effects lead to reduced adherence, the effectiveness of treating the underlying psychiatric condition may be compromised. [de Aquino Antonio Carlos Queiroz (2025); evidence level 1]
• Sexual side effects associated with antidepressants are diverse and encompass a range of symptoms. [de Aquino Antonio Carlos Queiroz (2025); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For maca menopause randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Kim Ji-Hyun (2025). Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. DOI: 10.3390/healthcare13243206. PMCID: PMC12732411. PMID: 41464280. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12732411/
• de Aquino Antonio Carlos Queiroz (2025). Pharmacological treatment of antidepressant-induced sexual dysfunction in women: A systematic review and meta-analysis of randomized clinical trials. DOI: 10.1016/j.clinsp.2025.100602. PMCID: PMC11904590. PMID: 39985829. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC11904590/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.